NZ-based infant milk producer, The a2 Milk Company (a2) is betting big on China’s stabilising economy, its government’s huge spending allocation on health, and the country’s demographic shifts to commit a huge investment in the country in the near future.
a2 Chief Executive David Bertolussi said a2 has agreed to extend it distribution partnership in China following its NZ$282 million (US$158.2 million) purchase of the Pokeno manufacturing facility from Mengniu Dairy, a deal that will allow it to manufacture more of its products and add new product lines targeting older consumers in China. It is targeting smaller Chinese cities and online sales.
China’s population has fallen for a 3rd straight year as higher living costs and changing social attitudes deter young families from having children. To counter this ongoing trend, the government had earlier scrapped the one-child policy and launched a Rmb 3000 (US$649)
Beyond scrapping the one-child policy, Beijing has launched 3000 yuan (US$422) annual childcare subsidies for each child under the age of 3 and pledged free preschool – its first national effort to slow the decline – while cities offer cash bonuses and housing perks for 2nd and 3rd child. The decline in birth rate is starting to taper off, according to Bertolussi. a2 expects the birth rate in China to stabilise in the near future.
Nevertheless, demand for infant formula milk is not expected to grow and will remain flat in the medium term. a2 milk has diversified its portfolio into products catering to other age groups including premium formulas and nutritional products designed for older consumers.
a2 further investment in China signifies its strong commitment to the market amid smooth trade relationship between China and New Zealand (NZ).